Arti Verma

672 total citations
29 papers, 519 citations indexed

About

Arti Verma is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Arti Verma has authored 29 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Arti Verma's work include Cancer-related gene regulation (4 papers), Congenital heart defects research (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Arti Verma is often cited by papers focused on Cancer-related gene regulation (4 papers), Congenital heart defects research (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Arti Verma collaborates with scholars based in United States, India and China. Arti Verma's co-authors include Payaningal R. Somanath, Abdulrahman Alwhaibi, Harika Sabbineni, Mir S. Adil, Sandeep Artham, Fei Gao, Devendra Kumar, Thresia Thomas, Sandhya K. Nair and S. Priya Narayanan and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Arti Verma

28 papers receiving 515 citations

Peers

Arti Verma

PRM

ONCOL

IMMUN

Jiaxiang Chen China

Nermin Ali Japan

Yaling Li China

Lei‐Yun Wang China

Zhihui Zhou China

Martina Monti Italy

Linlin Zhang China

Yu Yin China

Wenhao Niu China

Jiaxiang Chen China

Arti Verma

388 ×1.3

102 ×1.1

90 ×1.1

PRM

100 ×1.4

ONCOL

41 ×0.7

IMMUN

Citations per year, relative to Arti Verma Arti Verma (= 1×) peers Jiaxiang Chen

Countries citing papers authored by Arti Verma

Since Specialization

Citations

This map shows the geographic impact of Arti Verma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arti Verma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arti Verma more than expected).

Fields of papers citing papers by Arti Verma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arti Verma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arti Verma. The network helps show where Arti Verma may publish in the future.

Co-authorship network of co-authors of Arti Verma

This figure shows the co-authorship network connecting the top 25 collaborators of Arti Verma. A scholar is included among the top collaborators of Arti Verma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arti Verma. Arti Verma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alwhaibi, Abdulrahman, et al.. (2022). Regulation of Let-7a-5p and miR-199a-5p Expression by Akt1 Modulates Prostate Cancer Epithelial-to-Mesenchymal Transition via the Transforming Growth Factor-β Pathway. Cancers. 14(7). 1625–1625. 6 indexed citations

Verma, Arti, et al.. (2021). Inhibition of glypican-1 expression induces an activated fibroblast phenotype in a human bone marrow-derived stromal cell-line. Scientific Reports. 11(1). 9262–9262. 4 indexed citations

Adil, Mir S., et al.. (2021). Akt‐independent effects of triciribine on ACE2 expression in human lung epithelial cells: Potential benefits in restricting SARS‐CoV2 infection. Journal of Cellular Physiology. 236(9). 6597–6606. 8 indexed citations

Liu, Fang, Arti Verma, Mir S. Adil, et al.. (2021). Neuroprotective Effects of Fingolimod in a Cellular Model of Optic Neuritis. Cells. 10(11). 2938–2938. 7 indexed citations

Verma, Arti, et al.. (2020). Trends in hybrid cucumber development. Vegetable Science. 47(2). 274–284.

Verma, Arti, et al.. (2020). Possible treatment and strategies for COVID-19: review and assessment.. PubMed. 24(23). 12593–12608. 36 indexed citations

Verma, Arti, Sandeep Artham, & Payaningal R. Somanath. (2020). ALK-1 to ALK-5 ratio dictated by the Akt1-β-catenin pathway regulates TGFβ-induced endothelial-to-mesenchymal transition. Gene. 768. 145293–145293. 7 indexed citations

Artham, Sandeep, Arti Verma, Andrea Sikora, & Payaningal R. Somanath. (2020). Patients with acute respiratory distress syndrome exhibit increased stromelysin1 activity in the blood samples. Cytokine. 131. 155086–155086. 9 indexed citations

Verma, Arti, Sandeep Artham, Abdulrahman Alwhaibi, et al.. (2020). PAK1 inhibitor IPA-3 mitigates metastatic prostate cancer-induced bone remodeling. Biochemical Pharmacology. 177. 113943–113943. 18 indexed citations

10.

Alwhaibi, Abdulrahman, Arti Verma, Mir S. Adil, & Payaningal R. Somanath. (2019). The unconventional role of Akt1 in the advanced cancers and in diabetes-promoted carcinogenesis. Pharmacological Research. 145. 104270–104270. 70 indexed citations

11.

Artham, Sandeep, Fei Gao, Arti Verma, et al.. (2019). Endothelial stromelysin1 regulation by the forkhead box-O transcription factors is crucial in the exudative phase of acute lung injury. Pharmacological Research. 141. 249–263. 43 indexed citations

12.

Alwhaibi, Abdulrahman, Arti Verma, Sandeep Artham, Mir S. Adil, & Payaningal R. Somanath. (2019). Nodal pathway activation due to Akt1 suppression is a molecular switch for prostate cancer cell epithelial-to-mesenchymal transition and metastasis. Biochemical Pharmacology. 168. 1–13. 14 indexed citations

13.

Sabbineni, Harika, Arti Verma, Sandeep Artham, et al.. (2019). Pharmacological inhibition of β-catenin prevents EndMT in vitro and vascular remodeling in vivo resulting from endothelial Akt1 suppression. Biochemical Pharmacology. 164. 205–215. 33 indexed citations

14.

Gao, Fei, Abdulrahman Alwhaibi, Sandeep Artham, Arti Verma, & Payaningal R. Somanath. (2018). Endothelial Akt1 loss promotes prostate cancer metastasis via β-catenin-regulated tight-junction protein turnover. British Journal of Cancer. 118(11). 1464–1475. 38 indexed citations

15.

Sabbineni, Harika, Arti Verma, & Payaningal R. Somanath. (2018). Isoform‐specific effects of transforming growth factor β on endothelial‐to‐mesenchymal transition. Journal of Cellular Physiology. 233(11). 8418–8428. 65 indexed citations

16.

Gao, Fei, Abdulrahman Alwhaibi, Harika Sabbineni, et al.. (2017). Suppression of Akt1-β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis. Cancer Letters. 402. 177–189. 29 indexed citations

17.

Srivastava, Rohit, Pratibha Singh, Arti Verma, & Sunita Tiwari. (2015). "COMPARISON OF ACUTE MYOCARDIAL INFARCTION RISK FACTORS IN YOUNG AND ELDERLY PATIENTS- A CLINICO-EPIDEMIOLOGY STUDY". International Journal of Pharma and Bio Sciences. 2 indexed citations

18.

Mittal, RD, Priyanka Srivastava, Tulika Mittal, et al.. (2011). Association of death receptor 4, Caspase 3 and 5 gene polymorphism with increased risk to bladder cancer in North Indians. European Journal of Surgical Oncology. 37(8). 727–733. 19 indexed citations

19.

Nair, Sandhya K., Arti Verma, Thresia Thomas, et al.. (2006). Synergistic apoptosis of MCF-7 breast cancer cells by 2-methoxyestradiol and bis(ethyl)norspermine. Cancer Letters. 250(2). 311–322. 24 indexed citations

20.

Vijayanathan, Veena, et al.. (2006). Physiologic Levels of 2-Methoxyestradiol Interfere with Nongenomic Signaling of 17β-Estradiol in Human Breast Cancer Cells. Clinical Cancer Research. 12(7). 2038–2048. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact